New Anti-COVID Drug. Alike Dexamethasone Which Reduces Coronavirus Mortality
According to research from the University of Oxford, it saved the lives of one-third of seriously ill hospitalized patients.
A steroid against coronavirus. This is what was discovered by researchers, led by the University of Oxford that a drug would be an essential turning point in the fight against Covid-19, especially as regards severe condition patients.
It is Dexamethasone, a steroid anti-inflammatory readily available on the market which, according to research, saved the lives of one-third of seriously ill hospitalized patients. Mainly, this drug, after 28 days from the treatment, reduced deaths by 35% in COVID-19 positive patients who required urgent treatments with oxygen fans and by 20% in those who only needed oxygen as a supplement, however, that does not seem to be especially useful on patients in less severe conditions.
According to the scientists' estimates and trial, this drug, Dexamethasone would have avoided one death for every eight patients connected to respiratory machines such as ventilators and one for every twenty-five subjected to oxygen treatments.
Steroid drugs decrease inflammation and swelling, which sometimes happens in Covid-19 positive patients because the body immune system overreacts to fight the virus infection. This extreme body response can sustain fatally and has led doctors to diagnose with steroids medicines and other anti-inflammatory drugs. The World Health Organization (WHO) advises against using steroids in the early stages of the disease because they can slow down the expulsion time of the virus.
The study was conducted on an extensive and rigorous sample: 2,104 patients, randomly selected, were administered the drug and the results were compared with those obtained by 4,321 patients to whom the usual treatments were provided.
Britain will immediately begin administering Dexamethasone to coronavirus patients after a study has shown that the steroid saved the lives of one-third of the most severe cases. Said Mart Hancock, the Health Minister of Britain.
He also said that Britain started to expand the widely available drug when its potential became evident three months ago. "Since we spotted the first signs of dexamethasone's potential, we've been accumulating it since March," he said.
Peter Horby, professor of emerging infectious diseases at the Nuffield Department of Medicine, University of Oxford, said, "Dexamethasone is the first drug to be shown to improve survival with Covid-19. This is an extremely positive result."
"The survival benefit is clear and broad in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become a standard drug to be administered in these cases."
"Dexamethasone - added Horby - is cheap, available and can be used immediately to save lives all over the world ".